Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition.
Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition. Am J Transplant. 2020 12; 20(12):3620-3630.